Pimavanserin

Pimavanserin is a medication designed to treat hallucinations and delusions that can occur in Parkinson’s disease psychosis. It works by targeting specific brain receptors called serotonin receptors, helping to reduce psychotic symptoms without affecting movement control, which is a common concern with other antipsychotics. Unlike typical antipsychotics, Pimavanserin is less likely to cause side effects like movement issues. It is prescribed for individuals with Parkinson’s disease experiencing visual hallucinations or paranoid thoughts, aiming to improve their quality of life while minimizing additional motor complications.